These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 24394112
41. Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. Trentin C, Dominelli V, Maisonneuve P, Menna S, Bazolli B, Luini A, Cassano E. Breast; 2012 Oct; 21(5):635-40. PubMed ID: 22795363 [Abstract] [Full Text] [Related]
43. Predictors of invasive breast cancer in mammographically detected microcalcification in patients with a core biopsy diagnosis of flat epithelial atypia, atypical ductal hyperplasia or ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy. Catteau X, Simon P, Noël JC. Pathol Res Pract; 2012 Apr 15; 208(4):217-20. PubMed ID: 22445178 [Abstract] [Full Text] [Related]
44. [Ductal carcinoma in situ (DCIS): an always present reality; which treatment? Role of sentinel lymph node]. Buonomo O, Granai AV, Piccirillo R, Felici A, Cossu E, Cipriani C, Casciani CU, Roselli M. Suppl Tumori; 2002 Apr 15; 1(3):S65-8. PubMed ID: 12415792 [No Abstract] [Full Text] [Related]
45. National Breast Cancer Audit: ductal carcinoma in situ management in Australia and New Zealand. Cuncins-Hearn A, Boult M, Babidge W, Zorbas H, Villanueva E, Evans A, Oliver D, Kollias J, Reeve T, Maddern G. ANZ J Surg; 2007 Apr 15; 77(1-2):64-8. PubMed ID: 17295824 [Abstract] [Full Text] [Related]
46. Extensive pure ductal carcinoma in situ of the breast: identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery. Guillot E, Vaysse C, Goetgeluck J, Falcou MC, Couturaud B, Fitoussi A, Fourchotte V, Laki F, Malhaire C, Sigal-Zafrani B, Sastre-Garau X, Bollet MA, Mosseri V, Reyal F. Breast; 2014 Apr 15; 23(2):97-103. PubMed ID: 24388733 [Abstract] [Full Text] [Related]
47. Sentinel lymph node biopsy for ductal carcinoma in situ: an evolving approach at the University of Florida. Camp R, Feezor R, Kasraeian A, Cendan J, Schell S, Wilkinson E, Copeland E, Lind S. Breast J; 2005 Apr 15; 11(6):394-7. PubMed ID: 16297082 [Abstract] [Full Text] [Related]
49. Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ? Ansari B, Boughey JC, Adamczyk DL, Degnim AC, Jakub JW, Morton MJ. Am J Surg; 2012 Sep 15; 204(3):290-3. PubMed ID: 22749764 [Abstract] [Full Text] [Related]
50. Ductal carcinoma in situ of the breast: our experience. Ruggiero R, Procaccini E, Sanguinetti A, Cremone C, Gili S, Docimo G, Docimo L, Sparavigna L, Gubitosi A, Parmeggiani D, Avenia N. G Chir; 2009 Mar 15; 30(3):121-4. PubMed ID: 19351465 [Abstract] [Full Text] [Related]
51. Utility of intraoperative frozen section examination of sentinel lymph nodes in ductal carcinoma in situ of the breast. Ballehaninna UK, Chamberlain RS. Clin Breast Cancer; 2013 Oct 15; 13(5):350-8. PubMed ID: 23791128 [Abstract] [Full Text] [Related]
56. Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD. Curr Surg; 2005 Oct 15; 62(2):253-7. PubMed ID: 15796952 [Abstract] [Full Text] [Related]
57. The impact of sentinel lymph node biopsy in patients with a core biopsy diagnosis of ductal carcinoma in situ. Hung WK, Ying M, Chan M, Mak KL, Chan LK. Breast Cancer; 2010 Oct 15; 17(4):276-80. PubMed ID: 19756924 [Abstract] [Full Text] [Related]